TNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Tango Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$23.53+1.49 (+6.76%)
Close on Oct 19, 2026
- Market cap
- $3.53B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Tango Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 19, 2026 | Jun 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 9, 2026 | Jun 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 8, 2026 | Jun 8, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2026 | Jun 4, 2026 | SEC EDGAR |
| Current report | 8-K | May 13, 2026 | May 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 7, 2026 | May 8, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 16, 2026 | Apr 17, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 10, 2026 | Apr 15, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2026 | Mar 5, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 7, 2026 | Jan 8, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 2, 2026 | Jan 5, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 18, 2025 | Nov 21, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2025 | Nov 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 23, 2025 | Oct 24, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 23, 2025 | Oct 23, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 21, 2025 | Aug 25, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2025 | Jun 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 21, 2025 | Apr 21, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 10, 2022 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2024 | Nov 6, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 7, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 7, 2024 | Aug 7, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2024 | Jun 6, 2024 | SEC EDGAR |
| Current report | 8-K | May 23, 2024 | May 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | May 8, 2024 | May 8, 2024 | SEC EDGAR |